ANIP - ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.

52W High

$96.56

52W Low

$52.50

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.63

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

11.99

EV/EBITDA (<8 favorable)

27.98

EV/Revenue (<3 favorable)

3.33

P/S (TTM) (<3 favorable)

2.77

P/B (<3 favorable)

4.74

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

10.42%

Institutions (25–75% balanced)

97.79%

Shares Outstanding

21,688,800

Float

16,991,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

747,399,000

Gross Profit (TTM)

456,392,000

EPS (TTM)

-0.69

Profit Margin (>10% good)

-0.01%

Operating Margin (TTM) (higher better)

0.07%

ROE (TTM) (>15% strong)

-0.02%

EPS YoY (Quarterly) (>10% good)

-0.17

Revenue YoY (Quarterly) (>8% good)

0.53

Momentum

Bearish momentum

Value

6.0310

6.2699

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025